Unicycive Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value [Line Items]
Warrant liability	$ 9,147			$ 18,936
Total liabilities at fair value	9,147			18,936
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value [Line Items]
Warrant liability
Total liabilities at fair value
Significant Other Observable Inputs (Level 2) [Member]
Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value [Line Items]
Warrant liability
Total liabilities at fair value
Significant Unobservable Inputs (Level 3) [Member]
Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value [Line Items]
Warrant liability	9,147	$ 10,214	$ 10,588	18,936	$ 6,377	$ 8,131	$ 24,941	$ 13,134
Total liabilities at fair value	$ 9,147			$ 18,936